Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

Clinical trial NCT01672879 · TERMINATED

Trial details

NCT number: NCT01672879
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Fibrosis Due to NASH

Start date: 2012-10-29
Primary completion: 2016-09-26
Enrollment: 259

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.